- Home
- CAC vs ARCT Comparison
CAC vs ARCT Comparison
Compare CAC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | ARCT |
|---|---|---|
| Founded | 1875 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.5M | 194.1M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CAC | ARCT |
|---|---|---|
| Price | $42.96 | $6.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $47.33 | $38.67 |
| AVG Volume (30 Days) | 78.6K | ★ 700.6K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 9.13 | N/A |
| EPS | ★ 3.49 | N/A |
| Revenue | ★ $215,172,000.00 | $97,601,000.00 |
| Revenue This Year | $44.50 | N/A |
| Revenue Next Year | $7.82 | N/A |
| P/E Ratio | $12.42 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $34.53 | $5.85 |
| 52 Week High | $46.80 | $24.17 |
Technical Indicators
Market Signals| Indicator | CAC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 35.13 |
| Support Level | $43.60 | $6.02 |
| Resistance Level | $46.80 | $6.75 |
| Average True Range (ATR) | 0.87 | 0.31 |
| MACD | -0.46 | 0.09 |
| Stochastic Oscillator | 9.75 | 13.13 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.